Correlation Between Scully Royalty and Enlivex Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Scully Royalty and Enlivex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scully Royalty and Enlivex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scully Royalty and Enlivex Therapeutics, you can compare the effects of market volatilities on Scully Royalty and Enlivex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scully Royalty with a short position of Enlivex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scully Royalty and Enlivex Therapeutics.

Diversification Opportunities for Scully Royalty and Enlivex Therapeutics

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Scully and Enlivex is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Scully Royalty and Enlivex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enlivex Therapeutics and Scully Royalty is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scully Royalty are associated (or correlated) with Enlivex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enlivex Therapeutics has no effect on the direction of Scully Royalty i.e., Scully Royalty and Enlivex Therapeutics go up and down completely randomly.

Pair Corralation between Scully Royalty and Enlivex Therapeutics

Considering the 90-day investment horizon Scully Royalty is expected to generate 0.46 times more return on investment than Enlivex Therapeutics. However, Scully Royalty is 2.18 times less risky than Enlivex Therapeutics. It trades about -0.07 of its potential returns per unit of risk. Enlivex Therapeutics is currently generating about -0.12 per unit of risk. If you would invest  788.00  in Scully Royalty on September 3, 2024 and sell it today you would lose (37.00) from holding Scully Royalty or give up 4.7% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Scully Royalty  vs.  Enlivex Therapeutics

 Performance 
       Timeline  
Scully Royalty 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scully Royalty has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Scully Royalty is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.
Enlivex Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable essential indicators, Enlivex Therapeutics is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Scully Royalty and Enlivex Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Scully Royalty and Enlivex Therapeutics

The main advantage of trading using opposite Scully Royalty and Enlivex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scully Royalty position performs unexpectedly, Enlivex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enlivex Therapeutics will offset losses from the drop in Enlivex Therapeutics' long position.
The idea behind Scully Royalty and Enlivex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance